| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |